Skip to content

Cognitive

P021

Also called P21

InjectableEvidence CEvery day
Half-life
6hours
Typical vial
10mg
Research amounts
1–5mg

per administration

Common schedule
Every day
Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded30units dialled
Concentration
3.33mg/mL
Volume per draw
0.3mL
Units to dial
30
Doses per cartridge
10

Vial label

Copy this into your label printer.

Published research contexts for P021 describe 15 mg per administration. Descriptive only, not a recommendation.

No human pharmacokinetics; the figure is an order-of-magnitude placeholder from rodent work where it is reported to be orally active.

Evidence is preclinical: a ciliary neurotrophic factor (CNTF)–derived, adamantylated peptidomimetic studied in rodent neurogenesis and tau models and reported to be orally active. No human dose-ranging data exists and no amount or schedule is established, so the figures here are nominal and no schedule table is shown.

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak
1.07× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
30hours

About five half-lives

Administrations
7/ week

Where these numbers come from

  • P021 CNTF-peptidomimetic literature (Iqbal/Kazim)A CNTF-derived compound reported to raise neurogenesis and lower tau pathology in mouse models; no human dosing literature.

Next steps